Aureus Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.86M Buy
5,293
+4
+0.1% +$1.43K 0.12% 77
2025
Q4
$1.73M Buy
5,289
+17
+0.3% +$5.39K 0.11% 76
2025
Q3
$1.49M Sell
5,272
-483
-8% -$140K 0.1% 78
2025
Q2
$1.61M Buy
5,755
+106
+2% +$30K 0.1% 79
2025
Q1
$1.76M Buy
5,649
+3,628
+180% +$1.07M 0.12% 76
2024
Q4
$527K Sell
2,021
-60
-3% -$17.8K 0.03% 121
2024
Q3
$671K Sell
2,081
-30
-1% -$9.81K 0.04% 110
2024
Q2
$660K Sell
2,111
-485
-19% -$142K 0.05% 104
2024
Q1
$738K Buy
2,596
+914
+54% +$267K 0.05% 100
2023
Q4
$484K Buy
1,682
+87
+5% +$23.7K 0.04% 121
2023
Q3
$429K Buy
1,595
+650
+69% +$162K 0.03% 127
2023
Q2
$210K Sell
945
-208
-18% -$48.3K 0.02% 171
2023
Q1
$279K Sell
1,153
-21
-2% -$5.16K 0.02% 147
2022
Q4
$308K Buy
+1,174
New +$315K 0.03% 148
2022
Q2
Sell
-988
Closed -$239K 185
2022
Q1
$239K Hold
988
0.02% 195
2021
Q4
$222K Sell
988
-30
-3% -$6.33K 0.01% 192
2021
Q3
$216K Sell
1,018
-4,795
-82% -$1.1M 0.01% 196
2021
Q2
$1.42M Sell
5,813
-2,693
-32% -$662K 0.09% 93
2021
Q1
$2.12M Sell
8,506
-3,709
-30% -$885K 0.16% 58
2020
Q4
$2.81M Sell
12,215
-4,155
-25% -$958K 0.24% 47
2020
Q3
$4.16M Sell
16,370
-191
-1% -$47.3K 0.39% 38
2020
Q2
$3.91M Sell
16,561
-1,075
-6% -$245K 0.43% 37
2020
Q1
$3.58M Sell
17,636
-2,199
-11% -$480K 0.5% 35
2019
Q4
$4.78M Buy
19,835
+1,112
+6% +$245K 0.53% 38
2019
Q3
$3.62M Sell
18,723
-1,430
-7% -$274K 0.45% 41
2019
Q2
$3.71M Buy
20,153
+1,940
+11% +$347K 0.46% 40
2019
Q1
$3.46M Sell
18,213
-170
-0.9% -$32.5K 0.46% 39
2018
Q4
$3.58M Sell
18,383
-256
-1% -$49.9K 0.56% 39
2018
Q3
$3.86M Sell
18,639
-2,000
-10% -$394K 0.49% 41
2018
Q2
$3.81M Sell
20,639
-880
-4% -$156K 0.52% 40
2018
Q1
$3.67M Sell
21,519
-1,280
-6% -$235K 0.55% 40
2017
Q4
$3.96M Buy
22,799
+410
+2% +$72.6K 0.61% 40
2017
Q3
$4.17M Buy
22,389
+225
+1% +$39.9K 0.66% 39
2017
Q2
$3.82M Buy
22,164
+3,365
+18% +$547K 0.64% 40
2017
Q1
$3.01M Sell
18,799
-756
-4% -$126K 0.52% 42
2016
Q4
$2.86M Sell
19,555
-2,922
-13% -$440K 0.56% 42
2016
Q3
$3.75M Buy
22,477
+3,827
+21% +$647K 0.75% 41
2016
Q2
$2.84M Buy
18,650
+1,805
+11% +$281K 0.61% 42
2016
Q1
$2.53M Sell
16,845
-2,085
-11% -$310K 0.55% 40
2015
Q4
$3.07M Sell
18,930
-209
-1% -$32.9K 0.69% 37
2015
Q3
$2.65M Buy
19,139
+118
+0.6% +$18.6K 0.66% 40
2015
Q2
$2.92M Buy
19,021
+370
+2% +$59.3K 0.61% 47
2015
Q1
$2.98M Buy
18,651
+316
+2% +$49.8K 0.69% 45
2014
Q4
$2.92M Buy
18,335
+200
+1% +$31.2K 0.71% 46
2014
Q3
$2.55M Buy
18,135
+1,150
+7% +$150K 0.64% 45
2014
Q2
$2.01M Sell
16,985
-2,660
-14% -$308K 0.5% 47
2014
Q1
$2.42M Sell
19,645
-811
-4% -$98.4K 0.62% 47
2013
Q4
$2.33M Sell
20,456
-660
-3% -$75.1K 0.63% 46
2013
Q3
$2.36M Sell
21,116
-630
-3% -$68.3K 0.81% 47
2013
Q2
$2.15M Buy
+21,746
New +$2.26M 0.77% 49

Other funds holding AMGN

Aureus Asset Management's AMGN Position: Q1 2026 in Review

Aureus Asset Management increased its Amgen (AMGN) stake by 0.08% in Q1 2026, buying an estimated $1.43K and bringing the position to 5,293 shares worth $1.86M. The position accounts for 0.12% of the portfolio, ranked #77.

Aureus Asset Management first reported a position in AMGN in Q2 2013 and has held it in 50 quarters since. The position peaked at $4.78M in Q4 2019. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Aureus Asset Management held 5,293 shares of Amgen worth $1.86M as of Q1 2026.
  • Aureus Asset Management bought 4 Amgen shares in Q1 2026, an estimated $1.43K.
  • Amgen made up 0.12% of Aureus Asset Management's portfolio in Q1 2026, its #77 holding.
  • Aureus Asset Management first reported a position in Amgen in Q2 2013 and has held it in 50 quarters since.
  • Aureus Asset Management's Amgen position peaked at $4.78M in Q4 2019.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Aureus Asset Management's 13F filing for Q1 2026, filed 13 May 2026.